AU2001249262A1 - Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof - Google Patents
Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereofInfo
- Publication number
- AU2001249262A1 AU2001249262A1 AU2001249262A AU4926201A AU2001249262A1 AU 2001249262 A1 AU2001249262 A1 AU 2001249262A1 AU 2001249262 A AU2001249262 A AU 2001249262A AU 4926201 A AU4926201 A AU 4926201A AU 2001249262 A1 AU2001249262 A1 AU 2001249262A1
- Authority
- AU
- Australia
- Prior art keywords
- allergy
- asthma
- treatment
- methods
- therapeutic compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/92—Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19062000P | 2000-03-20 | 2000-03-20 | |
| US60190620 | 2000-03-20 | ||
| PCT/US2001/008726 WO2001070737A2 (en) | 2000-03-20 | 2001-03-20 | Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001249262A1 true AU2001249262A1 (en) | 2001-10-03 |
Family
ID=22702088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001249262A Abandoned AU2001249262A1 (en) | 2000-03-20 | 2001-03-20 | Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020082268A1 (en) |
| AU (1) | AU2001249262A1 (en) |
| WO (1) | WO2001070737A2 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| US7671200B2 (en) | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| US7009049B2 (en) | 2002-02-15 | 2006-03-07 | Cytokinetics, Inc. | Syntheses of quinazolinones |
| CA2485148A1 (en) | 2002-05-09 | 2003-11-20 | Cytokinetics, Inc. | Pyrimidinone compounds, compositions and methods |
| WO2003097053A1 (en) | 2002-05-09 | 2003-11-27 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| AU2003265242A1 (en) | 2002-05-23 | 2003-12-22 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| AU2003236527A1 (en) | 2002-06-14 | 2003-12-31 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| US7211580B2 (en) | 2002-07-23 | 2007-05-01 | Cytokinetics, Incorporated | Compounds, compositions, and methods |
| AU2003277079A1 (en) | 2002-09-30 | 2004-05-04 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| BRPI0412285A (en) | 2003-07-02 | 2006-09-19 | Hoffmann La Roche | arylamine-substituted quinazolinone compounds |
| WO2005061460A1 (en) | 2003-12-08 | 2005-07-07 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| AU2013288265B2 (en) | 2012-07-09 | 2017-04-06 | Lupin Limited | Tetrahydroquinazolinone derivatives as PARP inhibitors |
| UY35675A (en) | 2013-07-24 | 2015-02-27 | Novartis Ag | SUBSTITUTED DERIVATIVES OF QUINAZOLIN-4-ONA |
| JP7163180B2 (en) | 2015-09-25 | 2022-10-31 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ・リミテツド | 3-Hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulators |
| HUE054382T2 (en) | 2016-12-30 | 2021-09-28 | Mitobridge Inc | Poly-ADP ribose polymerase (PARP) inhibitors |
| EP3521269A1 (en) | 2018-02-06 | 2019-08-07 | Clariant Plastics & Coatings Ltd | Process for preparation of 1-nitrobenzene-2-alkyloxycarbonyl-5-carboxylic acid |
-
2001
- 2001-03-20 AU AU2001249262A patent/AU2001249262A1/en not_active Abandoned
- 2001-03-20 WO PCT/US2001/008726 patent/WO2001070737A2/en not_active Ceased
- 2001-03-20 US US09/813,096 patent/US20020082268A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020082268A1 (en) | 2002-06-27 |
| WO2001070737A3 (en) | 2002-01-31 |
| WO2001070737A2 (en) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001249262A1 (en) | Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof | |
| AU2003206311A1 (en) | Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases | |
| AU2003206310A1 (en) | Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases | |
| AU2003256253A1 (en) | Aerosol for medical treatment and methods | |
| AUPR839001A0 (en) | Dosage form, device and methods of treatment | |
| PL366636A1 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
| AU2002219229A1 (en) | Means for the diagnosis and therapy of CTCL | |
| PL350845A1 (en) | Compounds and methods for treatment of asthma, allergy and inflammatory disorders | |
| GB0004531D0 (en) | The treatment of respiratory diseases | |
| AU2001293891A1 (en) | New combination for the treatment of asthma | |
| TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
| AU2001285156A1 (en) | Combination therapy for the treatment of migraine | |
| AU2003269257A1 (en) | Use of cap-1 for the therapy of asthma | |
| AU2908501A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
| AU2002221510A1 (en) | A pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof | |
| AU2728301A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
| IL157272A0 (en) | Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds | |
| AU2002219473A1 (en) | Treatment of asthma and other lung conditions | |
| AU2001268762A1 (en) | Treatment and therapy apparatus | |
| HK1068789A (en) | Dosage form, device and methods of treatment | |
| AU2002365654A1 (en) | Treatment of diseases via the skin | |
| AU2001243044A1 (en) | Asthma treatment | |
| AU2002319479A1 (en) | Secretin for the treatment of asthma | |
| AU2002238541A1 (en) | Invasomes for the treatment of disease states, production and use thereof | |
| AU2001255255A1 (en) | Therapeutic compounds and methods |